Drug Trial Radar · NCT06713135
A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy
Last checked: Nov 19, 2026Latest source record: Apr 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Nov 10, 2024
Primary completion
Sep 2028
Study completion Sep 2028
Sponsor
- Lead sponsor
- Santhera PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Dec 3, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to assess safety and effectivness of long-term treatment with vamorolone in boys with Duchenne Muscular Dystrophy (DMD) who have completed prior studies with vamorolone.
Conditions
- Duchenne Muscular Dystrophy
Interventions
vamorolone 40 mg/mL oral suspensionDrug
Vamorolone is administered at a dose range between 2 mg/kg/day and 6 mg/kg/day for boys weighing \<40 kg. For boys weighing 40 kg or above, the dose range will be 80 mg to 240 mg once daily. Doses can be adjusted within the dose range as determined by the Investigator based on tolerability. The highest tolerated dose should be used.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of vertebral fractures per 1000 person-years based on X-ray central reading.Time frame: At Enrolment and every 2 years during a Full visit
Locations
18 sites in 9 countries. Site status is shown where the registry gives one.
UZ Gent (Universitair Ziekenhuis Gent)
Ghent, Belgium
UZ Leuven (Universitair Ziekenhuis Leuven)
Leuven, Belgium
University Hospital Brno
Brno, Czechia
Fakultni Nemocnice Motol
Prague, Czechia
Children's Hospital Agia Sofia
Athens, Greece
Children's Health Ireland at Tallaght, Tallaght University Hospital
Dublin, Ireland
Schneider Children's Medical Center
Petah Tikva, Israel
Leiden University Medical Center
Leiden, Netherlands
Radboud University Nijmegen
Nijmegen, Netherlands
Te Wao Nui - Child Health Service, Wellington Hospital
Wellington, New Zealand
Hospital Universitario Puerta de Hierro Majadahonda
Madrid, Spain
Hospital Universitario y Politecnico de La Fe
Valencia, Spain
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
Great Ormond Street Hospital for Children NHS Foundation Trust
London, United Kingdom
The John Walton Muscular Dystrophy Research Centre
Newcastle, United Kingdom
Queen Elizabeth University Hospital
Glasgow, Lanarkshire, United Kingdom
Alder Hey Children's Hospital
Liverpool, Merseyside, United Kingdom
Leeds Teaching Hospitals NHS Trust
Leeds, West Yorkshire, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.